A predictive risk‐scoring model for survival prognosis of multiple myeloma based on gain/amplification of 1q21: Experience in a tertiary hospital in South‐Western China
The UHR model, which integrates the presence of +1q21 with no-ASCT and TP53 deletion, is designed to identify the early relapse subgroup among patients with +1q21 in NDMM.
Authors
- Shanshan Liang (ORCID: https://orcid.org/0000-0001-6276-0265)
- Ling Pan
- Wenjiao Tang (ORCID: https://orcid.org/0000-0001-5576-1788)
- Yuhuan Zheng (ORCID: https://orcid.org/0000-0002-5855-4343)
- Li Zhang (ORCID: https://orcid.org/0009-0004-8547-1326)
- Ting Niu
- Yanqiu Xiong
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- Chengdu University (CN)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1002/cam4.70193
- Citations
- 3
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.36